Related Experiment Videos
Endothelium-derived hyperpolarizing factor
1Institut de Recherches Servier, Courbevoie, France.
Clinical and Experimental Pharmacology & Physiology
|December 1, 1996
Summary
Endothelium-derived hyperpolarizing factor (EDHF) contributes to blood vessel relaxation beyond nitric oxide. Its exact identity remains elusive, though it involves potassium channels and is diminished in aging and disease.
Area of Science:
- Vascular biology and physiology
- Endothelial function and dysfunction
- Cardiovascular pharmacology
Background:
- Endothelium-dependent relaxations are not fully explained by nitric oxide (NO) or prostacyclin.
- An unidentified endothelium-derived hyperpolarizing factor (EDHF) contributes to vascular smooth muscle hyperpolarization and relaxation.
- EDHF-mediated responses are distinct from NO-mediated pathways and vary across species.
Purpose of the Study:
- To investigate the mechanisms and characteristics of endothelium-derived hyperpolarizing factor (EDHF).
- To explore the ion channel involvement in EDHF-mediated hyperpolarization.
- To assess the potential role of arachidonic acid metabolites and the impact of aging and disease on EDHF.
Main Methods:
- Comparative studies of blood vessels from different species (canine, porcine, human, rat, guinea-pig, rabbit).
- Pharmacological inhibition of nitric oxide synthase (NOS), cyclo-oxygenase, and specific ion channels (ATP-dependent and calcium-dependent potassium channels).
- Investigation using glibenclamide, tetraethylammonium (TEA), apamin, charybdotoxin, and cytochrome P450 inhibitors.
Main Results:
- EDHF-mediated hyperpolarizations are resistant to NOS and cyclo-oxygenase inhibitors.
- Glibenclamide-sensitive hyperpolarizations suggest NO involvement, while glibenclamide-insensitive hyperpolarizations implicate calcium-dependent potassium channels (sensitive to TEA, apamin, charybdotoxin).
- Epoxyeicosatrienoic acids (cytochrome P450 metabolites) may contribute to EDHF, but their role is not definitively proven across all species; EDHF is more critical in smaller arteries and diminished in aging/disease models.
Conclusions:
- EDHF is a significant contributor to endothelium-dependent vascular relaxation, acting via potassium channels.
- The precise identity of EDHF remains uncertain, with epoxyeicosatrienoic acids being a potential candidate.
- Understanding EDHF's role and identifying its specific mediators are crucial for comprehending vascular physiology and pathology, especially in aging and disease states.